| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| Other Sizes |
|
Purity: ≥98%
Cathepsin Inhibitor 1 (CTS-IN-1) is a novel and potent inhibitor of Cathepsin (L, L2, S, K, B) with the potential to be used in the treatment of osteoarthritis. With respective pIC50 values of 7.9, 6.7, 6.0, 5.5, and 5.2, it inhibits Cathepsin (L, L2, S, K, and B). With underlying bone damage and articular cartilage loss leading to joint instability and pain, osteoarthritis is now understood to be a chronic degenerative disease. One possible target for intervention in the treatment of osteoarthritis is the lysosomal cysteine protease2 Cathepsin L (CatL). Major components of articular cartilage, such as aggrecan4 and type II collagen, are proteoglycans that can be degraded by CatL once it is secreted into the extracellular matrix.
| Targets |
Cathepsin L (pIC50 = 7.9); Cathepsin L2 (pIC50 = 6.7); Cathepsin S (pIC50 = 6); Cathepsin K (pIC50 = 5.5); Cathepsin B (pIC50 = 5.2)
|
||
|---|---|---|---|
| ln Vitro |
Cathepsin Inhibitor 1 (compound 25) is a cathepsin (L, L2, S, K, B) inhibitor with pIC50 values of 7.9, 6.7, 6.0, 5.5, and 5.2, in that order.
|
||
| ln Vivo |
|
||
| Animal Protocol |
|
||
| References |
| Molecular Formula |
C20H24CLN5O2
|
|
|---|---|---|
| Molecular Weight |
401.89
|
|
| Exact Mass |
401.16
|
|
| Elemental Analysis |
C, 59.77; H, 6.02; Cl, 8.82; N, 17.43; O, 7.96
|
|
| CAS # |
225120-65-0
|
|
| Related CAS # |
|
|
| Appearance |
Solid powder
|
|
| SMILES |
CC(C)(C)C1=NN(C(=C1)C(=O)N[C@@H](CC2=CC(=CC=C2)Cl)C(=O)NCC#N)C
|
|
| InChi Key |
MZRVIHRERYCHBL-HNNXBMFYSA-N
|
|
| InChi Code |
InChI=1S/C20H24ClN5O2/c1-20(2,3)17-12-16(26(4)25-17)19(28)24-15(18(27)23-9-8-22)11-13-6-5-7-14(21)10-13/h5-7,10,12,15H,9,11H2,1-4H3,(H,23,27)(H,24,28)/t15-/m0/s1
|
|
| Chemical Name |
5-tert-butyl-N-[(2S)-3-(3-chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]-2-methylpyrazole-3-carboxamide
|
|
| Synonyms |
|
|
| HS Tariff Code |
2934.99.9001
|
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
|
|---|
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4882 mL | 12.4412 mL | 24.8824 mL | |
| 5 mM | 0.4976 mL | 2.4882 mL | 4.9765 mL | |
| 10 mM | 0.2488 mL | 1.2441 mL | 2.4882 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA